yes, but randomization does not guarantee equivalency of all variables at baseline. its not uncommon for a few baseline parameters to still be skewed despite others being evenly split. the baseline is just such an easy thing to show in the graph that i found it surprising they didnt include it since it would clearly drive home the point of efti's MOA being clinically confirmed.
anyway, i messaged marc and hope he is able to confirm the baseline cd8 was the same for both groups - any pharma partner/acquirer would require this information
otherwise, presentation looks great!
yes, but randomization does not guarantee equivalency of all...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $432.1M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 28.5¢ | $397.8K | 1.349M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 423337 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 166981 | 17 |
View Market Depth
| Last trade - 13.02pm 08/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |